Our health experts designed and are now implementing the monitoring and evaluation framework for Stop TB Partnership's TB REACH initiative.
We have been commissioned by the Stop TB Partnership to evaluate whether the work undertaken by the TB REACH grantees has had an impact on the efforts to detect and control TB in 46 countries worldwide.
- Since 2010, we have monitored 112 TB REACH projects to improve the effectiveness, efficiency and impact of grantees' work.
- With each wave of funding, Mott MacDonald and partners the Dutch Royal Tropical Institute (KIT), have adapted the monitoring framework to meet the client’s needs.
- The first wave of results found that the project had helped to put on treatment an average of 25% more people with confirmed TB compared to the year before.
- Our current contract with KTI is now in its third wave.
We designed the whole monitoring and evaluation process and has continued to adapt it through 112 TB REACH projects and three waves of funding.
The third wave was launched with a greater focus on early case detection and the use of GeneXpert technology. GeneXpert technology offers more accurate diagnosis and can reduce time to appropriate treatment.
We are also reporting on more qualitative data to improve the sustainability of TB REACH as part of the evolving monitoring and evaluation framework.
Value and benefits
The first wave of results released found that by using a range of innovations to increase case detection, TB REACH partners were able to put on treatment an average of 25% more people with confirmed TB compared to the year before.
Based on historical trends, the project areas would normally have seen a 1.2% annual rise in the number of people found with TB – the equivalent of 820 people. With the TB REACH interventions a 25.9% increase was observed, which equates to 18,043 people.
The careful monitoring of TB REACH projects is creating a clear evidence base of what technologies and approaches can help prevent the spread of TB.